Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Tadashi, Nakahama, Makoto, Toda, Hironobu, Watanabe, Atsuyuki, Hashimoto, Katsushi, Terasaka, Ritsuko, Nakamura, Kazufumi, Yamada, Nobuyuki, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649238/
https://www.ncbi.nlm.nih.gov/pubmed/23762606
http://dx.doi.org/10.1155/2013/518968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649238/
https://www.ncbi.nlm.nih.gov/pubmed/23762606
http://dx.doi.org/10.1155/2013/518968

Ejemplares similares